PROGNOSTIC AND DIAGNOSTIC VALUE OF NGAL AND KIM-1 IN PATIENTS WITH ACUTE KIDNEY INJURY TREATED WITH ANTIBIOTICS
- Авторлар: Nikitin E.Y.1, Drozdov V.N.1, Vorobieva O.A.1, Astapovsky A.A.1, Khalaidzheva K.N.1, Shikh E.V.1
-
Мекемелер:
- I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
- Шығарылым: Том 8, № 4 (2022)
- Беттер: 49-55
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/289000
- DOI: https://doi.org/10.18565/therapy.2022.4.49-55
- ID: 289000
Дәйексөз келтіру
Аннотация
Толық мәтін
Авторлар туралы
Evgeniy Nikitin
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: e.u.nikitin@ya.ru
postgraduate student of Department of clinical pharmacology and propaedeutics of internal diseases 119991, Moscow, 8/2 Trubetskaya Str
Vladimir Drozdov
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: vndrozdov@yandex.ru
Dr. med. habil., professor, professor of the Department of clinical pharmacology and propaedeutics of internal diseases 119991, Moscow, 8/2 Trubetskaya Str
Olga Vorobieva
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: asturia777@mail.ru
postgraduate student of the Department of clinical pharmacology and propaedeutics of internal diseases 119991, Moscow, 8/2 Trubetskaya Str
Alexander Astapovsky
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: al.astapovskii@gmail.com
postgraduate student of the Department of clinical pharmacology and propaedeutics of internal diseases 119991, Moscow, 8/2 Trubetskaya Str
Ksenia Khalaidzheva
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: kseniyakhalaidzheva@mail.ru
postgraduate student of the Department of clinical pharmacology and propaedeutics of internal diseases 119991, Moscow, 8/2 Trubetskaya Str
Evgenia Shikh
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: chih@mail.ru
Dr. med. habil., professor, head of the Department of clinical pharmacology and propaedeutics of internal diseases 119991, Moscow, 8/2 Trubetskaya Str
Әдебиет тізімі
- Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012; 2(1): 1-138. https://dx.doi.org/10.1038/kisup.2012.1.
- Susantitaphong P., Cruz D.N., Cerda J. et al. Acute Kidney Injury Advisory Group of the American Society of Nephrology. World incidence of AKI: A meta-analysis. Clin J Am Soc Nephrol. 2013 ;8(9): 1482-93. https://dx.doi.org/10.2215/CJN.00710113. Erratum in: Clin J Am Soc Nephrol. 2014; 9(6): 1148.
- Silver S.A., Long J., Zheng Y., Chertow G.M. Cost of acute kidney injury in hospitalized patients. J Hosp Med. 2017; 12(2): 70-76. https://dx.doi.org/10.12788/jhm.2683.
- Zeng X., McMahon G.M., Brunelli S.M. et al. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol. 2014; 9(1): 12-20. https://dx.doi.org/10.2215/CJN.02730313.
- Kerr M., Bedford M., Matthews B., O'Donoghue D. The economic impact of acute kidney injury in England. Nephrol Dial Transplant. 2014; 29(7): 1362-68. https://dx.doi.org/10.1093/ndt/gfu016.
- Vaidya V.S., Ferguson M.A., Bonventre J.V. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008; 48: 463-93. https ://dx.doi.org/10.1146/a nnurev.pharmtox.48.113006.094615.
- Bao G., Clifton M., Hoette T.M. et al. Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol. 2010; 6(8): 602-9. https://dx.doi.org/10.1038/nchembio.402.
- Schroll A., Eller K., Feistritzer C. et al. Lipocalin-2 ameliorates granulocyte functionality: innate immunity. Eur J Immunol. 2012; 42(12): 3346-57. https://dx.doi.org/10.1002/eji.201142351.
- Goetz D.H. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002; 10(5): 1033-43. https://dx.doi.org/10.1016/s1097-2765(02)00708-6.
- Schmidt-Ott K.M., Mori K., Li J.Y. et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 2007; 18(2): 407-13. https://dx.doi.org/10.1681/ASN.2006080882.
- Mori K., Lee H.T., Rapoport D. et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005; 115(3): 610-21. https://dx.doi.org/10.1172/JCI23056.
- Ichimura T., Bonventre J.V., Bailly V. et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998; 273(7): 4135-42. https://dx.doi.org/10.1074/jbc.273.7.4135.
- Shao X., Tian L., Xu W. et al. Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury: A meta-analysis. PLoS One. 2014; 9(1): e84131. https://dx.doi.org/10.1371/journal.pone.0084131.
- Chen J.J., Lee T.H., Lee C.C., Chang C.H. Using lipocalin as a prognostic biomarker in acute kidney injury. Expert Rev Mol Diagn. 2021; 21(5): 455-64. https://dx.doi.org/10.1080/14737159.2021.1917384.
- Jahaj E., Vassiliou A.G., Pratikaki M. et al. Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) could provide better accuracy than creatinine in predicting acute kidney injury development in critically ill patients. J Clin Med. 2021; 10(22): 5379. https://dx.doi.org/10.3390/jcm10225379.
- Bonventre J.V., Yang L. Kidney injury molecule-1. Curr Opin Crit Care. 2010; 16(6): 556-61. https://dx.doi.org/10.1097/MCC.0b013e32834008d3.
- Lee C.W., Kou H.W., Chou H.S. et al. A combination of SOFA score and biomarkers gives a better prediction of septic AKI and in-hospital mortality in critically ill surgical patients: A pilot study. World J Emerg Surg. 2018; 13: 41. https://dx.doi.org/10.1186/s13017-018-0202-5.